Bayer AG (/ˈbeɪər/ or /ˈbaɪər/); German pronunciation: [ˈbaɪ̯ɐ]... -

Bayer AG (/ˈbeɪər/ or /ˈbaɪər/); German pronunciation: [ˈbaɪ̯ɐ]...

wikipedia - 15 Sep 2016
Bayer AG (/ˈbeɪər/ or /ˈbaɪər/); German pronunciation: [ˈbaɪ̯ɐ]) is a German multinational chemical, pharmaceutical and life sciences company. It is headquartered in Leverkusen, where its illuminated sign is a landmark. Bayer's primary areas of business include human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals and biotechnology products; and high value polymers. The company is a component of the Euro Stoxx 50 stock market index. The company's motto is "science

Bayer gains Russian approval for Monsanto deal

MarketWatch - 20 Apr 2018
Bayer AG (BAYN.XE) said Friday that Russian antitrust authorities have approved its proposed $57 billion acquisition of Monsanto Co. MON, +0.32% on the condition that the German company transfers certain technologies to Russian recipients. Under the ...

Russia gives green light to Bayer's takeover of Monsanto: Ifax

Reuters - 20 Apr 2018
MOSCOW (Reuters) - Russia's anti-monopoly regulator FAS has approved Bayer's (BAYGn.DE) takeover of Monsanto (MON.N), Russian news agency Interfax reported on Friday, citing the regulator. FILE PHOTO: Monsanto is displayed on a screen where the stock ...

Bundesliga Live: Borussia Dortmund vs. Bayer Leverkusen

Deutsche Welle - 21 Apr 2018
+++ All times in CET, refresh page for updates +++. Borussia Dortmund 3 - 0 Bayer Leverkusen (Sancho 13', Reus 55', Philipp 63') Signal Iduna Park, Dortmund. 74' - Perhaps I spoke too soon. Brandt finds Volland with a low cross but his shot is well ...

Bayer, J&J Can't Nix Xarelto Case Midtrial, Patient Says

Law360 - 20 Apr 2018
Law360 (April 20, 2018, 7:15 PM EDT) -- A patient suing units of Bayer AG and Johnson & Johnson over the blood thinner Xarelto pushed back Thursday against the drugmakers' midtrial motion to throw out the case, saying testimony showed his prescribing ...

Bayer shareholder Temasek to boost share capital

MarketWatch - 17 Apr 2018
Bayer AG (BAYN.XE) said late Monday that investment company Temasek has signed an agreement to increase its share capital in the German company. Temasek has subscribed to 31 million new Bayer shares, which equals around 3.6 percent of Bayer's capital ...

Easton Pharmaceuticals Announces BAYER Agreement Update

GlobeNewswire (press release) - 16 Apr 2018
TORONTO, ON, April 16, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) Announces update to its signed agreement with BAYER's subsidiary company, Bayer Consumer Care. As previously announced, Easton Pharmaceuticals, through its partner ...

FDA Threatens Bayer With Penalties Over Contraceptive Device

Bloomberg - 09 Apr 2018
Bayer's device, which is an alternative to sterilization surgeries, was first approved in 2002 and is the only product of its kind on the market. Sales of the device have declined sharply since the warnings were added, and Bayer stopped selling the ...

Alexei Bayer: The inevitability of fascism

Kyiv Post - 21 Apr 2018
Last week I was in Hungary, where Prime Minister Viktor Orbán had just won his third straight landslide electoral victory. Afterwards, tens of thousands of mostly young and educated Hungarians came out into the streets of Budapest to demand a new ...

Bayer, J&J Urge Judge To Ax Philly Xarelto Case Midtrial

Law360 - 19 Apr 2018
Law360 (April 19, 2018, 6:41 PM EDT) -- Bayer AG and Johnson & Johnson units have urged a Philadelphia judge to throw out an ongoing trial alleging the companies didn't provide an adequate warning for blood-thinner Xarelto, saying there was no evidence ...

Bayer to Divest 3.6% Stake to Singapore Company Temasek - 18 Apr 2018
Per the deal, Bayer will issue to a subsidiary of Temasek at an at-market price the new registered (no-par value) shares with an entitlement to dividends as of Jan 1, 2017. Bayer stated that the proceeds from the placement would be taken into account ...

MiraLAX Generics Get FDA Reprieve Despite Bayer Objections

Law360 - 20 Apr 2018
Law360 (April 20, 2018, 7:13 PM EDT) -- Sales of generic versions of popular constipation drug MiraLAX will be allowed for an extra six months, the U.S. Food and Drug Administration revealed Friday, rejecting opposition from Bayer AG and reversing the ...

What's New